CHA Submits Energy and Commerce Committee Statement on Oversight of the 340B Drug Pricing Program

CHA Submits Energy and Commerce Committee Statement on Oversight of the 340B Drug Pricing Program

Children's Hospital Association urges the committee to work with provider stakeholders to enhance the effectiveness and integrity of the program for children's health.
DOWNLOAD

The House Energy and Commerce Subcommittee on Oversight and Investigations held a hearing titled, “Oversight of the 340B Drug Pricing Program.” The discussion focused on the 340B drug pricing program’s impact on patients, the health care system, and potential reforms.

Children's Hospital Association submitted a statement expressing our strong support for the program as well as our concerns about the 340B ACCESS Act and urged the committee to work with provider stakeholders to further enhance the effectiveness and integrity of the program. 

Hand

Contact Us

For more information, connect with us.

(202) 753-5337

Related Content

Summary of Laboratory Developed Tests Final Rule

Children's Hospital Association sent a letter to Energy and Commerce leaders supporting pediatric-focused legislation included in a recent markup.

July 17, 2024

Addressing Pediatric Drug and Supply Shortages

Children’s hospitals depend on a reliable and safe drug and supply chain to provide life-saving treatments to their pediatric patients.

June 11, 2024

CHA Comments on Stimulant Medication Shortages

Children’s health groups are asking HHS and the DEA to convene stakeholders to identify actionable solutions about ongoing stimulant medication shortages.

May 23, 2024